COMPOUNDS, PROCESS FOR THE MANUFACTURE, PHARMACEUTICAL COMPOSITIONS UNDERSTANDING THEM, A METHOD FOR THERAPEUTIC AND / OR PROPHYLATIC TREATMENT THAT ARE MODULATED BY LXR ALPHA AND / OR LXR BETA AGONISTS AND USE OF THE COMPOUNDS.

• 收藏
• 分享

专利权人:

F. HOFFMANN-LA ROCHE AG.

发明人:

HENRIETTA DEHMLOW,ULRIKE OBST SANDER,STEPHAN ROEVER,BERND KUHN,TANJA SCHULZ-GASCH,MATTHEW WRIGHT

申请号：

BRPI0809680

公开号：

BRPI0809680A2

申请日:

2008.03.18

申请国别(地区):

BR

年份:

2014

代理人:

摘要：

The invention is concerned with novel imidazolidinone derivatives of formula (I): wherein R1 to R11 and X are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds bind to LXR alpha and LXR beta and can be used in pharmaceutical compositions.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/